Ibrutinib

In this video, Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program and Staff Physician at the Cleveland Clinic Taussig Cancer Institute, discusses emerging therapies and drugs for mantle cell lymphoma treatment, and the potential utility of non-covalent BTK inhibitors.

In this video, Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program and Staff Physician at the Cleveland Clinic Taussig Cancer Institute, discussed recent advancements in MCL treatment, specifically the introduction of oral BTK inhibitors and CAR T-cell therapies.

In this video, Bijal Shah, MD, MS, an associate professor in the malignant hematology department at Moffitt Cancer Center, discussed updates to the SHINE trial, and its role in the treatment of mantle cell lymphoma, as well as findings of ZUMA-2 and how it impacts clinical practice.

In this video, Brad Kahl, MD, a professor in the oncology division of the Washington University School of Medicine in St. Louis, discusses recent advancements in the treatment and study of mantle cell lymphoma, including why he calls the last year a particularly productive one.